万维提示：
1、投稿方式：在线投稿。
2、期刊网址：https://journals.sagepub.com/home/cms
3、投稿网址：https://mc.manuscriptcentral.com/jcms
4、官网邮箱：JofCMS@gmail.com（编辑部）
5、期刊刊期：双月刊，一年出版6期。
2021年7月28日星期三
投稿须知【官网信息】
Manuscript Submission Guidelines:
Please read the guidelines below then visit the Journal of Cutaneous Medicine and Surgery (JCMS)’s submission site https://mc.manuscriptcentral.com/jcms to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned. Remember you can log in to the submission site at any time to check on the progress of your paper through the peer review process.
SAGE Publishing disseminates high-quality research and engaged scholarship globally, and we are committed to diversity and inclusion in publishing. We encourage submissions from a diverse range of authors from across all countries and backgrounds.
Only manuscripts of sufficient quality that meet the aims and scope of the Journal of Cutaneous Medicine and Surgery will be reviewed.
As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere. Please see our guidelines on prior publication and note that JCMS may accept submissions of papers that have been posted on pre-print servers; please alert the Editorial Office when submitting (contact details are at the end of these guidelines) and include the DOI for the preprint in the designated field in the manuscript submission system. Authors should not post an updated version of their paper on the preprint server while it is being peer reviewed for possible publication in the journal. If the article is accepted for publication, the author may re-use their work according to the journal's author archiving policy. If your paper is accepted, you must include a link on your preprint to the final version of your paper.
This journal is a member of the Committee on Publication Ethics (COPE).
This Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).
There are no fees payable to submit or publish in this journal.
If you have any questions about publishing with SAGE, please visit the SAGE Journal Solutions Portal.
1. What do we publish?
1.1 Aims & Scope
Before submitting your manuscript, please ensure you have read the Aims & Scope.
Journal of Cutaneous Medicine and Surgery is a bimonthly, refereed journal, which aims to reflect the state of the art in cutaneous biology and medical and surgical dermatology by providing original scientific writings, as well as complete critical reviews of the dermatology literature for clinicians, trainees, and academicians. The journal endeavours to bring readers cutting-edge dermatologic information by featuring scholarly research and articles on issues of basic and applied science, and in-depth reviews, all of which provide a theoretical framework for practitioners to make sound practical decisions. The evolving fields of dermatology and dermatologic surgery are highlighted through these articles.
1.2 Article types
Journal of Cutaneous Medicine and Surgery invites you to submit original research articles, reviews of dermatologic disease and\or therapy, visual dermatology, and clinical correspondence for inclusion in upcoming issues of the journal. Manuscripts must be original material, not under simultaneous consideration by another publication, and dealing with the clinical and research aspects of skin disease and skin biology. Brief presentations reporting new or unusual information or procedures, and Letters to the Editor, with or without illustrations, are welcome.
JCMS is an English language journal and submissions must be presented in a style and grammar consistent with the highest standards of English publications.
JCMS encourages images for publication and will publish these in colour at no cost to the authors. However, these images must be artfully formatted and of superior technical quality.
JCMS utilizes online video and web casting that can be linked to manuscripts in the journal print format. These presentations must be of superior technical quality and expand the scientific information presented within the manuscript.
All accepted manuscripts will be published online ahead of print.
Original Research. Original, in-depth clinical and investigative research manuscripts will be given the highest priority for publication. Preference will be given to research that will enhance the understanding of cutaneous disease or impact the medical and/or surgical practice of dermatology.
The manuscript must be concise and the utilization of figures, tables and diagrams is encouraged. The use of supplementary files may be useful for supporting materials. Manuscripts should not exceed 3000 words, excluding the abstract, references, tables, and figure legends.
Review Articles. These scholarly articles should provide a current, authoritative, referenced discussion of a disease or medical and\or surgical treatment. The purpose of these articles is to inform the practice of dermatology by critically reviewing the current understanding and\or treatment of the condition. The use of illustrations and figures is encouraged. Review articles should not include case reports, e.g. “a Case Report and Review of the Literature.” Case Reports should be submitted to JCMS Case Reports at http://www.sagepub.com/jcmscr. Review articles may be submitted by authors for publication consideration or solicited by the Editor. All Review articles are subject to peer review. Manuscripts should not exceed 4500 words, excluding the abstract, references, tables, and figure legends.
Clinical Correspondence. These submissions should not include specific case reports. (Case Reports should be submitted to JCMS Case Reports at http://www.sagepub.com/jcmscr). These letters also should not be subdivided into sections, e.g. Introduction, Methods, Results, Discussion, etc., and should not exceed 500 words, excluding references (limit 5).
Medical Letters. Novel or preliminary research findings and early reports of therapeutic trials may be considered for publication as a Medical Letter.
Surgical Letters. Novel or preliminary research findings and early reports of novel surgical techniques may be considered for publication as a Surgical Letter. The association of on-line video to complement the letter is encouraged.
Research Letters. Letters, by invitation, commenting on translational research of importance to the clinical dermatologist.
Letters to the Editor. Letters to the Editor regarding previously published material should be submitted within one month of publication of the reference subject. Letters should have a descriptive title and be concise. References may be published as Supplementary Data. The introduction of new data and unsubstantiated claims or opinions will not be permitted. Each letter will be submitted to the author of the original paper for response, which, if supplied and accepted, will be published simultaneously with the letter. Final publication of either letter is at the discretion of the Editor.
1.2.1 Photo-Only Submissions
Visual Dermatology. These photo submissions by a maximum of two authors will use one unique, high quality medical image to “tell the story” without words. Short (up to 1 minute) video clips are also acceptable (a quality still image from the video must be included). A very brief statement (25 words or less; no references) of the diagnosis and perhaps the diagnostic tests to enhance the understanding of the image may be included. The brief title should include the disease/condition. These are NOT case reports; the presentation is to highlight the image. The images may not have been submitted or published elsewhere. Submissions that do not meet these guidelines will be returned without review.
1.3 Writing your paper
The SAGE Author Gateway has some general advice and on how to get published, plus links to further resources.
See 4. Preparing your manuscript for submission for section specific information.
1.3.1 Make your article discoverable
For information and guidance on how to make your article more discoverable, visit our Gateway page on How to Help Readers Find Your Article Online.
2. Editorial policies
2.1 Peer review policy
The Journal of Cutaneous Medicine and Surgery recognizes the value and importance of peer review in
maintaining the integrity of the scientific record. The peer review process is essential to scholarly publication both as a critique and a collaboration to improve the quality of the manuscript. All manuscripts are reviewed initially by the Editors and only those papers that meet the language, scientific and editorial standards of the journal, and fit within the aims and scope of the journal, will be circulated for further peer review.
The Journal of Cutaneous Medicine and Surgery adheres to a conventional single-blind reviewing policy in which the identities of the reviewers are always concealed from the author(s). In addition to the editorial review, individual manuscripts are reviewed by at least two referees. Visual Dermatology, Clinical Correspondence, and Letters to the Editor may not require peer review or may receive less than two reviews after the Editor’s assessment. Once a reviewer accepts the privilege of reviewing the manuscript, the reviewer is requested to submit their review within 2 weeks. An editorial decision is generally reached within a week of receipt of all reviews; generally within 6 weeks of submission. Manuscripts requiring revision, whether minor or major, must be resubmitted for further peer review after revision.
The Editor or members of the Editorial Board may occasionally submit their own manuscripts for publication consideration. In these cases, the peer review process will be managed by alternative members of the Board and the submitting Editor/Board member will have no involvement in the decision-making process.
Recommended or Opposed Reviewers
As part of the submission process, you are permitted but not required to provide the names of 3 peers who could be called upon to review your manuscript. Recommended reviewers should be experts in their fields and should be able to provide an objective assessment of the manuscript. Please be aware of any conflicts of interest when recommending reviewers. Examples of conflicts of interest include (but are not limited to) the below:
The reviewer should have no prior knowledge of your submission
The reviewer should not have recently collaborated with any of the authors
Reviewer nominees from the same institution as any of the authors are not permitted
You are also permitted but not required to identify peers who you do not wish to review your manuscript (opposed reviewers).
Please note that the Editors are not obliged to invite/reject any recommended/opposed reviewers to assess your manuscript.
Publons
JCMS is committed to delivering high quality, fast peer-review for your paper, and as such has partnered with Publons. Publons is a third party service that seeks to track, verify and give credit for peer review. Reviewers for JCMS can opt in to Publons in order to claim their reviews or have them automatically verified and added to their reviewer profile. Reviewers claiming credit for their review will be associated with the relevant journal, but the article name, reviewer’s decision and the content of their review is not published on the site. For more information, visit the Publons website.
2.2 Authorship
Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors.
The list of authors should include all those who can legitimately claim authorship. This is all those who:
(i) Made a substantial contribution to the concept or design of the work; or acquisition, analysis or interpretation of data,
(ii) Drafted the article or revised it critically for important intellectual content,
(iii) Approved the version to be published,
(iv) Participated sufficiently in the work to take public responsibility for appropriate portions of the content.
Authors should meet the conditions of all of the points above. When a large, multicentre group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship.
Acquisition of funding, collection of data, or general supervision of the research group alone does not
constitute authorship, although all contributors who do not meet the criteria for authorship, including medical writers, should be listed in the Acknowledgments section. Please refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on authorship.
2.3 Acknowledgements
All contributors who do not meet the criteria for authorship should be listed in an Acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, or a department chair who provided only general support.
Any acknowledgements should appear first at the end of your article prior to your Declaration of Conflicting Interests (if applicable), any notes and your References.
2.3.1 Third party submissions
Where an individual who is not listed as an author submits a manuscript on behalf of the author(s), a statement must be included in the Acknowledgements section of the manuscript and in the accompanying cover letter. The statements must:
Disclose this type of editorial assistance – including the individual’s name, company and level of input
Identify any entities that paid for this assistance
Confirm that the listed authors have authorized the submission of their manuscript via third party and approved any statements or declarations, e.g. conflicting interests, funding, etc.
Where appropriate, SAGE reserves the right to deny consideration to manuscripts submitted by a third party rather than by the authors themselves.
2.3.2 Writing assistance
Individuals who provided writing assistance, e.g. from a specialist communications company, do not qualify as authors but should be included in the Acknowledgements section. Authors must disclose any writing assistance – including the individual’s name, company and level of input – and identify the entity that paid for this assistance. It is not necessary to disclose use of language polishing services.
2.4 Funding
The Journal of Cutaneous Medicine and Surgery requires all authors to acknowledge their funding in a
consistent fashion under a separate heading. Please visit the Funding Acknowledgements page on the SAGE Journal Author Gateway to confirm the format of the acknowledgment text in the event of funding, or state that: "This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors."
2.5 Declaration of conflicting interests
It is the policy of JCMS to require a declaration of conflicting interests from all authors, enabling a statement to be carried within the paginated pages of all published articles.
Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of your manuscript, after any acknowledgements and prior to the references. If no conflict exists, please state that: "The Author(s) declare(s) that there is no conflict of interest". for guidance on conflict of interest statements, please see the ICMJE recommendations here.
2.6 Research ethics and patient consent
Medical research involving human subjects must be conducted according to the World Medical Association Declaration of Helsinki.
Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers reporting animal and/or human studies must state in the methods section that the relevant Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number.
For research articles, authors are also required to state in the methods section whether participants provided informed consent and whether the consent was written or verbal.
Information on informed consent to report individual cases or case series should be included in the manuscript text. A statement is required regarding whether written informed consent for patient information and images to be published was provided by the patient(s) or a legally authorized representative. Please do not submit the patient’s actual written informed consent with your article, as this in itself breaches the patient’s confidentiality. The Journal requests that you confirm to us, in writing, that you have obtained written informed consent but the written consent itself should be held by the authors/investigators themselves, for example in a patient’s hospital record. The confirmatory letter may be uploaded with your submission as a separate file.
A statement is required regarding whether written informed consent for patient images to be published was provided by the patient(s) or a legally authorized representative. Basic masking in photos is not sufficient to ensure patient anonymity; signed consent is required.
Please also refer to the ICMJE Recommendations for the Protection of Research Participants.
All research involving animals submitted for publication must be approved by an ethics committee with
oversight of the facility in which the studies were conducted. The journal has adopted the Consensus Author Guidelines on Animal Ethics and Welfare for Veterinary Journals published by the International Association of Veterinary Editors.
2.7 Clinical trials
The Journal of Cutaneous Medicine and Surgery conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrollment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.
……
更多详情：
https://journals.sagepub.com/author-instructions/CMS
